Skip to main
CYRX

CryoPort (CYRX) Stock Forecast & Price Target

CryoPort (CYRX) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CryoPort is a unique company that is well-positioned to benefit from the growing demand for cell and gene therapies. Their strong financial performance and expanding market share in the Life Sciences Services segment demonstrate their strong competitive position in the market. The company's investment in facilities and expansion into new markets, such as China, demonstrate their commitment to continued growth and innovation. With a strong management team and a positive outlook for the future, I am bullish on CryoPort's stock and believe it has the potential for significant upside in the coming years.

Bears say

CryoPort is currently overvalued and trading above its five-year range of 1.9-5.2x EV/Revenue. The company has seen strong growth in its Life Sciences Services segment, but its Life Sciences Products segment has experienced slow growth due to a tough comp. Despite potential upside in the year, the fundamental reasons for a negative outlook on the stock include its current valuation and potential for future competition in the market.

CryoPort (CYRX) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 83% of analysts recommend a Strong Buy, 17% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CryoPort and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CryoPort (CYRX) Forecast

Analysts have given CryoPort (CYRX) a Strong Buy based on their latest research and market trends.

According to 6 analysts, CryoPort (CYRX) has a Strong Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CryoPort (CYRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.